HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Lecomte Selected Research

Neuroendocrine Carcinoma

6/2020Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma.
10/2015Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Lecomte Research Topics

Disease

55Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 08/2002
35Neoplasms (Cancer)
12/2022 - 08/2002
14Adenocarcinoma
01/2022 - 12/2014
11Neoplasm Metastasis (Metastasis)
12/2022 - 01/2005
8Pancreatic Neoplasms (Pancreatic Cancer)
05/2020 - 06/2002
6Rectal Neoplasms (Rectal Cancer)
04/2022 - 08/2019
5Microsatellite Instability
05/2022 - 07/2016
5Crohn Disease (Crohn's Disease)
01/2022 - 11/2003
5Colonic Neoplasms (Colon Cancer)
01/2022 - 12/2009
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 04/2016
5Neutropenia
03/2021 - 01/2010
3Disease Progression
01/2022 - 10/2011
3Hepatocellular Carcinoma (Hepatoma)
03/2021 - 12/2008
2Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022 - 09/2015
2Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 02/2021
2Ankylosing Spondylitis
01/2022 - 10/2016
2Rheumatoid Arthritis
01/2022 - 10/2016
2Thrombocytopenia (Thrombopenia)
03/2021 - 01/2017
2COVID-19
01/2021 - 01/2020
2Neuroendocrine Carcinoma
06/2020 - 10/2015
2Mucositis
12/2019 - 01/2017
2Fatigue
12/2019 - 01/2017
2Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
10/2019 - 02/2015
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2006 - 04/2005
1Frailty
01/2022
1Cachexia
01/2022
1Necrosis
01/2022
1Primitive Neuroectodermal Tumors (PNET)
01/2022
1Sarcopenia
11/2021
1Esophageal Stenosis (Esophageal Stricture)
09/2021
1Asthenia
03/2021
1Hemorrhage
03/2021
1Liver Failure
03/2021
1Lymphopenia (Lymphocytopenia)
01/2021

Drug/Important Bio-Agent (IBA)

12Monoclonal AntibodiesIBA
01/2022 - 10/2009
12Fluorouracil (Carac)FDA LinkGeneric
12/2020 - 06/2002
10GemcitabineFDA Link
09/2019 - 06/2002
9Bevacizumab (Avastin)FDA Link
12/2022 - 12/2008
9Cetuximab (Erbitux)FDA Link
01/2022 - 09/2008
7Leucovorin (Folinic Acid)FDA Link
12/2020 - 06/2002
7Irinotecan (Camptosar)FDA LinkGeneric
12/2020 - 01/2010
6Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2015
5folfirinoxIBA
01/2022 - 09/2015
5Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2013
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 10/2009
4CalciumIBA
05/2022 - 06/2016
4Pharmaceutical PreparationsIBA
01/2022 - 12/2008
4130-nm albumin-bound paclitaxelIBA
09/2019 - 09/2015
4Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2018 - 05/2006
3afliberceptIBA
12/2022 - 01/2020
3Immune Checkpoint InhibitorsIBA
04/2022 - 01/2021
3Sunitinib (Sutent)FDA Link
01/2022 - 12/2008
3Infliximab (Remicade)FDA Link
01/2022 - 12/2015
3RamucirumabIBA
01/2022 - 01/2018
3Circulating Tumor DNAIBA
12/2021 - 07/2019
3PlatinumIBA
06/2020 - 09/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 11/2016
3Biological ProductsIBA
11/2016 - 01/2009
2Calcibiotic Root Canal SealerIBA
04/2022 - 08/2017
2Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
01/2022 - 04/2019
2Calcium Channels (Calcium Channel)IBA
01/2022 - 04/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2021
2AerosolsIBA
01/2022 - 09/2021
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022 - 02/2021
2EverolimusFDA Link
01/2022 - 12/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 06/2002
2BilirubinIBA
03/2021 - 12/2014
2Panitumumab (Vectibix)FDA Link
01/2021 - 02/2018
2Angiopoietin-2IBA
10/2020 - 03/2015
2eryaspaseIBA
05/2020 - 01/2020
2EnzymesIBA
12/2019 - 06/2004
2Indigo Carmine (Indigo Blue)IBA
10/2019 - 02/2015
2Carcinoembryonic AntigenIBA
01/2018 - 11/2016
2Matrix Metalloproteinases (MMPs)IBA
04/2005 - 01/2005
1CurcuminIBA
05/2022
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1PotassiumIBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1encorafenibIBA
01/2022
1UbiquitinIBA
01/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1pembrolizumabIBA
10/2021
1HydrogelsIBA
09/2021
1Ga(III)-DOTATOCIBA
02/2021
1durvalumabIBA
01/2021
1CateninsIBA
01/2021
1taxaneIBA
01/2021
1CrizotinibIBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1COVID-19 VaccinesIBA
01/2021

Therapy/Procedure

34Drug Therapy (Chemotherapy)
04/2022 - 09/2004
20Therapeutics
01/2022 - 06/2002
4Neoadjuvant Therapy
04/2022 - 06/2020
3Chemoradiotherapy
01/2021 - 10/2015
2Microbubbles
01/2022 - 01/2019
2Adjuvant Chemotherapy
01/2017 - 07/2016
1Immunotherapy
04/2022
1Enhanced Recovery After Surgery
01/2022
1Aftercare (After-Treatment)
01/2022